DDS vs GNTX
Dillard's, Inc. vs Gentex — AI-powered side-by-side comparison
DDS
Dillard's, Inc.
56
Watch
VS
| Metric | DDS | GNTX |
|---|
| AI Score |
56
|
71
|
| Price |
$648.33
|
$23.94
|
| P/E Ratio |
15.36×
|
12.66×
|
| ROE |
32.1%
|
15.5%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
37.8%
|
35.0%
|
| Debt / Equity |
0.27×
|
1.46×
|
| Dividend Yield |
4.8%
|
2.0%
|
| RSI (14) |
80.2
|
50.2
|
| Beta |
1.187
|
0.798
|
| Expected Upside |
—
|
+3.7%
|
AI Committee View
Current Innellis committee reasoning for DDS versus GNTX.
GNTX leads by 15 points.
GNTX scores 71/100 (Buy) versus DDS at 56/100 (Watch).
DDS Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -7.0% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- P/E of 14.9 is inexpensive for the broad market — Value
- ROE of 33.8% shows genuine earnings power backing the valuation — Value
- Price structure making higher highs and higher lows — Technical
Bear Case
- Price-to-book of 5.6x prices in significant intangible value — Value
- Revenue declining -7.0% YoY -- this is not a growth story right now — Growth
- EPS declining -6.7% YoY despite any revenue growth — Growth
GNTX Committee View
100% agreement
4 analysts
The primary driver is 3 consecutive earnings beats -- consistent execution. The main limiting factor is 2 existing position pair(s) are highly correlated already. The committee is constructive but not yet at full conviction.
Bull Case
- 3 consecutive earnings beats -- consistent execution — Growth
- Quarter-over-quarter growth rate is ACCELERATING, not just positive — Growth
- MACD histogram positive -- bullish momentum — Technical
Bear Case
- Both daily and weekly trends are bearish — strong multi-timeframe downtrend.